JAGUAR HEALTH
Live / Registered — Registered (as of 07 Sept 2021)
What this means for you
Registered since 07 Sept 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 07 Sept 2027, and its filing window is open now).
Record
- Serial number
- 87710258
- Registration number
- 6479253
- Mark type
- Design + words
- Filed
- 06 Dec 2017
- Published for opposition
- 22 May 2018
- Registered
- 07 Sept 2021
- Next maintenance filing
- §8 declaration of use, due by 07 Sept 2027 (grace period to 07 Mar 2028)
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; pharmaceutical preparations for the treatment and prevention of diarrhea; pharmaceutical preparations for the treatment of diarrhea; Veterinary pharmaceutical preparations containing botanical extracts, for the treatment of diarrhea in animals, namely, cows and horses
Owner
- Jaguar Health, Inc., San Francisco, CA, US
- Jaguar Health, Inc., San Francisco, CA, US
- Jaguar Health, Inc., San Francisco, CA, US
Prior registrations
Prosecution history
- 07 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 05 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jul 2021 — USE AMENDMENT FILED
- 29 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Jul 2021 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 19 Jul 2021 — TEAS STATEMENT OF USE RECEIVED
- 02 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Feb 2021 — SOU EXTENSION 5 GRANTED
- 15 Jan 2021 — SOU EXTENSION 5 FILED
- 15 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2020 — SOU EXTENSION 4 GRANTED
- 17 Jul 2020 — SOU EXTENSION 4 FILED